Comparison
11q Partial Monosomy Syndrome C0795841 vs 17 20 Lyase Deficiency Isolated C3277849
Clinical comparison between 11q Partial Monosomy Syndrome and 17 20 Lyase Deficiency Isolated for differential diagnosis and treatment planning.
11q Partial Monosomy Syndrome C0795841
A chromosomal disorder from missing genetic material on chromosome 11. It typically causes developmental delays, intellectual disability, and facial differences. Care focuses on symptom management and developmental interventions.
17 20 Lyase Deficiency Isolated C3277849
A rare enzymatic disorder affecting sex hormone production. Impairs development of sexual characteristics in both males and females. Treatment involves hormone supplementation.
6 comparison axes
Onset
11q Partial Monosomy Syndrome C0795841
0-0
17 20 Lyase Deficiency Isolated C3277849
0-18
Onset patterns differ
Severity
11q Partial Monosomy Syndrome C0795841
severe
17 20 Lyase Deficiency Isolated C3277849
severe
Different severity levels
Chronic
11q Partial Monosomy Syndrome C0795841
Chronic
17 20 Lyase Deficiency Isolated C3277849
Chronic
Differing course
Communicable
11q Partial Monosomy Syndrome C0795841
No
17 20 Lyase Deficiency Isolated C3277849
No
Different transmission
Body System
11q Partial Monosomy Syndrome C0795841
congenital
17 20 Lyase Deficiency Isolated C3277849
endocrine
Same/different system
Category
11q Partial Monosomy Syndrome C0795841
genetic
17 20 Lyase Deficiency Isolated C3277849
endocrine
Different category
Bottom line
11q-partial-monosomy-syndrome-C0795841 and 17-20-lyase-deficiency-isolated-C3277849 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 11q Partial Monosomy Syndrome C0795841 | 17 20 Lyase Deficiency Isolated C3277849 | Discriminating power |
|---|---|---|---|
| Developmental pattern | Developmental delay and intellectual disability are typical reported features. | Primary developmental disability is not established by the source description. | High |
| Physical differences | Facial differences may accompany the chromosomal disorder. | Impaired development of sexual characteristics is the described feature. | High |
| Hormone-related presentation | A primary sex-hormone enzyme defect is not described. | Sex-hormone production is impaired in both sexes. | High |
When to favor each condition
Choose 11q Partial Monosomy Syndrome C0795841 when
Congenital multisystem or developmental presentation
Source data support a chromosomal deletion affecting development from birth.
High
Suspected structural chromosome abnormality
Missing material on chromosome 11 is the stated etiology.
High
Need for developmental support planning
Care is described as symptom management and developmental intervention.
Moderate
Choose 17 20 Lyase Deficiency Isolated C3277849 when
Disordered sexual development or puberty
The source links the enzyme defect to impaired sexual characteristics.
High
Suspected isolated steroidogenic defect
Isolated 17,20-lyase deficiency is an endocrine enzyme disorder.
High
Consideration of hormone replacement
Treatment is described as hormone supplementation, without doses specified.
Moderate
How key tests differ
| Test | 11q Partial Monosomy Syndrome C0795841 | 17 20 Lyase Deficiency Isolated C3277849 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May identify missing chromosome 11 material. | Not expected to establish this enzyme diagnosis. | A chromosomal result supports the left condition only when clinically correlated. |
| Steroid hormone profile | No characteristic profile is established here. | May suggest impaired sex-steroid production; cutoffs are not supplied. | Abnormal hormones are findings, not a diagnosis by themselves. |
| Targeted genetic testing | May characterize the chromosomal deletion. | May assess genes relevant to isolated lyase deficiency. | Test selection and interpretation require specialist review. |
Prognosis comparison
11q Partial Monosomy Syndrome C0795841
- Outcome
- Chronic congenital condition with variable developmental impact; exact outcomes are not established.
- Factors
- Deletion extent, associated anomalies, and access to developmental care may influence course.
17 20 Lyase Deficiency Isolated C3277849
- Outcome
- Chronic endocrine condition; outcomes depend on diagnosis and hormone management, but specifics are not established.
- Factors
- Age at recognition, degree of hormone impairment, and treatment response may matter.
Time frame: Lifelong follow-up is generally relevant; precise timelines are not established.
Specialist care, early recognition, and individualized support influence both courses.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurodevelopment | Delays and intellectual disability are typical concerns. Not established as a core feature from the source. Support needs should be individualized. |
| Sexual development | Not identified as the defining problem. Impaired sexual characteristics may occur in both sexes. Endocrine follow-up is appropriate. |
| Long-term care burden | Chronic developmental and medical support may be needed. Chronic endocrine monitoring and hormone treatment may be needed. Exact complication rates are not established. |
Patient education highlights
- HighDifferent causes
One is a chromosomal deletion; the other is an isolated enzyme disorder affecting sex hormones.
- HighDiagnosis limits
An abnormal test does not alone confirm either diagnosis and needs clinician interpretation.
- MediumCare focus
Left-sided care emphasizes development; right-sided care may include hormone supplementation.